GLP-1 drugs, like Wegovy, Ozempic and Mounjaro, are a class of drugs created to treat diabetes and lower blood sugar that have grown in popularity as a weight loss treatment used by celebrities and others
While peptide-based GLP-1R agonists such as semaglutide have transformed the treatment landscape, dual incretin receptor engagement further enhances metabolic outcomes
But their broader impact on the clinical trials ecosystem may still be unfolding
Note that the numbers in parentheses (1, 2, etc.) are clickable links to these studies
Ozempic Kullanmnn Balca Faydalar Kan ekeri seviyelerini drr HbA1c deerinde anlaml azalma salar Ar yemek yeme isteini azaltr Ortalama %515 orannda kilo kaybna yardmc olabilir Kalp-damar hastalklar riskini azaltabilir Tip 2 diyabetin ilerlemesini yavalatabilir Yal karacier hastal zerinde olumlu etkileri olabilir Bu faydalar, diyabet ve obezite ile mcadele eden bireyler iin Ozempici etkili bir seenek hline getirir
AARP Hearing Center Are Peptides Safe for Older Adults